CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 45 filers reported holding CUREVAC N V in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,374,892 | -75.6% | 201,302 | -62.8% | 0.00% | -100.0% |
| Q2 2023 | $5,632,344 | +251.0% | 540,532 | +134.8% | 0.00% | – |
| Q1 2023 | $1,604,856 | -20.9% | 230,252 | -31.6% | 0.00% | – |
| Q4 2022 | $2,029,733 | -19.4% | 336,606 | +5.4% | 0.00% | – |
| Q3 2022 | $2,517,000 | -43.1% | 319,295 | -1.8% | 0.00% | -100.0% |
| Q2 2022 | $4,425,000 | +33.4% | 325,153 | +92.2% | 0.00% | – |
| Q1 2022 | $3,317,000 | +5.5% | 169,157 | +84.6% | 0.00% | – |
| Q4 2021 | $3,145,000 | -15.7% | 91,626 | +34.1% | 0.00% | -100.0% |
| Q3 2021 | $3,732,000 | +4.5% | 68,346 | +40.6% | 0.00% | – |
| Q2 2021 | $3,572,000 | -27.1% | 48,603 | -9.3% | 0.00% | -100.0% |
| Q1 2021 | $4,903,000 | +255.8% | 53,599 | +215.4% | 0.00% | – |
| Q4 2020 | $1,378,000 | +201.5% | 16,995 | +73.2% | 0.00% | – |
| Q3 2020 | $457,000 | – | 9,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |